Bloomberg Technology
Developing Antibodies for Covid-19
Sep.28 — Jennifer Bath, chief executive officer at Immunoprecise Antibodies Ltd., discusses the company’s potentially groundbreaking Covid-19 antibody treatment on “Bloomberg Technology.”
Sep.28 — Jennifer Bath, chief executive officer at Immunoprecise Antibodies Ltd., discusses the company’s potentially groundbreaking Covid-19 antibody treatment on “Bloomberg Technology.”